BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang S, Li L, Lin JY, Lin H. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. World J Gastroenterol 2003; 9(5): 899-904 [PMID: 12717827 DOI: 10.3748/wjg.v9.i5.899] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Makowski GS, Ramsby ML. Gelatinolytic and fibrinolytic activity in fresh-frozen plasma. J Biomed Sci 2004;11:531-3. [PMID: 15153789 DOI: 10.1007/BF02256103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Min-wen JC, Yan-jiang BC, Mishra S, Dai X, Magae J, Shyh-chang N, Kumar AP, Sethi G. Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy. Stress and Inflammation in Disorders. Elsevier; 2017. pp. 199-225. [DOI: 10.1016/bs.apcsb.2017.01.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
3 Lukaszewicz-Zając M, Mroczko B, Kornhuber J, Lewczuk P. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS). J Neural Transm (Vienna) 2014;121:469-77. [PMID: 24366530 DOI: 10.1007/s00702-013-1143-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
4 Alpízar-Alpízar W, Laerum OD, Christensen IJ, Ovrebo K, Skarstein A, Høyer-Hansen G, Ploug M, Illemann M. Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma. J Histochem Cytochem 2016;64:483-94. [PMID: 27370797 DOI: 10.1369/0022155416656173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
5 Long H, Zhou B, Jiang FG. Expression of MMP-2 and MMP-9 in retinoblastoma and their significance. Int J Ophthalmol 2011;4:489-91. [PMID: 22553708 DOI: 10.3980/j.issn.2222-3959.2011.05.06] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
6 Morelli C, Campioni K, Parolin C, Palù G, Tognon M. Activity of the matrix metalloproteinase-9 promoter in human normal and tumor cells. J Cell Physiol 2004;199:126-33. [PMID: 14978741 DOI: 10.1002/jcp.10450] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
7 Al-Batran SE, Pauligk C, Wirtz R, Werner D, Steinmetz K, Homann N, Schmalenberg H, Hofheinz RD, Hartmann JT, Atmaca A. The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer. Ann Oncol. 2012;23:1699-1705. [PMID: 22112973 DOI: 10.1093/annonc/mdr552] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
8 Kubben FJ, Sier CF, van Duijn W, Griffioen G, Hanemaaijer R, van de Velde CJ, van Krieken JH, Lamers CB, Verspaget HW. Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer. Br J Cancer. 2006;94:1035-1040. [PMID: 16538217 DOI: 10.1038/sj.bjc.6603041] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
9 Chan VY, Chan MW, Leung WK, Leung PS, Sung JJ, Chan FK. Intestinal trefoil factor promotes invasion in non-tumorigenic Rat-2 fibroblast cell. Regul Pept. 2005;127:87-94. [PMID: 15680474 DOI: 10.1016/j.regpep.2004.10.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
10 Kitahashi T, Sato K, Oka Y, Tsujiuchi T, Sakamoto A, Mitsui M, Mori T, Nakamura Y, Ohtsuki K, Tsutsumi M. Inhibition of Pancreatic Carcinogenesis by Shark Cartilage Proteoglycan in Hamsters. J Toxicol Pathol 2006;19:179-84. [DOI: 10.1293/tox.19.179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 de la Peña S, Sampieri CL, Ochoa-Lara M, León-Córdoba K, Remes-Troche JM. Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer. Dis Markers 2014;2014:285906. [PMID: 24669030 DOI: 10.1155/2014/285906] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
12 Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie. 2005;87:287-297. [PMID: 15781315 DOI: 10.1016/j.biochi.2005.01.014] [Cited by in Crossref: 198] [Cited by in F6Publishing: 183] [Article Influence: 11.6] [Reference Citation Analysis]
13 Zhao Q, Liu ZD, Xue Y, Wang JF, Li H, Tang QJ, Wang YM, Dong P, Xue CH. Ds-echinoside A, a new triterpene glycoside derived from sea cucumber, exhibits antimetastatic activity via the inhibition of NF-κB-dependent MMP-9 and VEGF expressions. J Zhejiang Univ Sci B 2011;12:534-44. [PMID: 21726060 DOI: 10.1631/jzus.B1000217] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
14 Alizadeh AM, Shiri S, Farsinejad S. Metastasis review: from bench to bedside. Tumour Biol 2014;35:8483-523. [PMID: 25104089 DOI: 10.1007/s13277-014-2421-z] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 10.1] [Reference Citation Analysis]
15 Jafari E, Safinejad S, Dabiri S, Naghibzadeh-Tahami A. Study of the Relationship between MMP-2 and MMP-9 and Her2/neu Overexpression in Gastric Cancer: Clinico- Pathological Correlations. Asian Pac J Cancer Prev 2021;22:811-7. [PMID: 33773545 DOI: 10.31557/APJCP.2021.22.3.811] [Reference Citation Analysis]
16 Matsumura S, Oue N, Nakayama H, Kitadai Y, Yoshida K, Yamaguchi Y, Imai K, Nakachi K, Matsusaki K, Chayama K. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol. 2005;131:19-25. [PMID: 15565457 DOI: 10.1007/s00432-004-0621-4] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 3.9] [Reference Citation Analysis]
17 Peng TL, Chen J, Mao W, Song X, Chen MH. Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9. BMC Cell Biol 2009;10:27. [PMID: 19371443 DOI: 10.1186/1471-2121-10-27] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
18 Łukaszewicz-Zając M, Mroczko B, Guzińska-Ustymowicz K, Pryczynicz A, Gryko M, Kemona A, Kędra B, Szmitkowski M. Matrix metalloproteinase 2 (MMP-2) and their tissue inhibitor 2 (TIMP-2) in gastric cancer patients. Adv Med Sci 2013;58:235-43. [PMID: 24384769 DOI: 10.2478/ams-2013-0018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
19 Hussain A, Harish G, Prabhu SA, Mohsin J, Khan MA, Rizvi TA, Sharma C. Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 expression. Cancer Epidemiol 2012;36:e387-93. [PMID: 22884883 DOI: 10.1016/j.canep.2012.07.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
20 Raja UM, Gopal G, Shirley S, Ramakrishnan AS, Rajkumar T. Immunohistochemical expression and localization of cytokines/chemokines/growth factors in gastric cancer. Cytokine. 2017;89:82-90. [PMID: 27793525 DOI: 10.1016/j.cyto.2016.08.032] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
21 Hu ZL, Wen JF, Liu Y, Wang KS, Zhen H, Fu CY. Effects of TGIF antisense oligonucleotide on proliferation and apoptosis of gastric carcinoma cells. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 530-532 [DOI: 10.11569/wcjd.v12.i3.530] [Reference Citation Analysis]
22 Chiranjeevi P, Spurthi KM, Rani NS, Kumar GR, Aiyengar TM, Saraswati M, Srilatha G, Kumar GK, Sinha S, Kumari CS, Reddy BN, Vishnupriya S, Rani HS. Gelatinase B (-1562C/T) polymorphism in tumor progression and invasion of breast cancer. Tumour Biol 2014;35:1351-6. [PMID: 24357512 DOI: 10.1007/s13277-013-1181-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
23 Vidal MTA, de Oliveira Araújo IB, Gurgel CAS, Pereira FDAC, Vilas-bôas DS, Ramos EAG, Agra IMG, Barros AC, Freitas VS, dos Santos JN. Density of mast cells and microvessels in minor salivary gland tumors. Tumor Biol 2013;34:309-16. [DOI: 10.1007/s13277-012-0552-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
24 Huang BJ, Xu HM, Zhao YJ, Wang TJ, Tian DT, Chen JQ. Multivariate analysis of predicting lymph node metastasis in gastric cancer. Shijie Huaren Xiaohua Zazhi 2004; 12(2): 266-270 [DOI: 10.11569/wcjd.v12.i2.266] [Reference Citation Analysis]
25 Auyeung KK, Woo PK, Law PC, Ko JK. Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells. J Ethnopharmacol 2012;141:635-41. [PMID: 21864667 DOI: 10.1016/j.jep.2011.08.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
26 Lian PL, Liu Z, Yang GY, Zhao R, Zhang ZY, Chen YG, Zhuang ZN, Xu KS. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer. World J Gastroenterol 2016; 22(14): 3852-3859 [PMID: 27076771 DOI: 10.3748/wjg.v22.i14.3852] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
27 Zhang Y, Qin L, Ma X, Wang Y, Wu Y, Jiang J. Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer. Dis Markers 2020;2020:8831466. [PMID: 33005257 DOI: 10.1155/2020/8831466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Boxler S, Djonov V, Kessler TM, Hlushchuk R, Bachmann LM, Held U, Markwalder R, Thalmann GN. Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer? Am J Pathol 2010;177:2216-24. [PMID: 20889560 DOI: 10.2353/ajpath.2010.091190] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
29 Grunnet M, Mau-Sørensen M, Brünner N. Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review. Scand J Gastroenterol 2013;48:899-905. [PMID: 23834019 DOI: 10.3109/00365521.2013.812235] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
30 Lukaszewicz-Zając M, Mroczko B, Szmitkowski M. Gastric cancer - The role of matrix metalloproteinases in tumor progression. Clin Chim Acta. 2011;412:1725-1730. [PMID: 21693112 DOI: 10.1016/j.cca.2011.06.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
31 Puig-Costa M, Oliveras-Ferraros C, Flaquer S, Llopis-Puigmarti F, Pujol-Amado E, Martin-Castillo B, Vazquez-Martin A, Cufí S, Ortiz R, Roig J, Codina-Cazador A, Menendez JA. Antibody microarray-based technology to rapidly define matrix metalloproteinase (MMP) signatures in patients undergoing resection for primary gastric carcinoma. J Surg Oncol 2011;104:106-9. [PMID: 21308687 DOI: 10.1002/jso.21887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
32 Emara M, Cheung PY, Grabowski K, Sawicki G, Wozniak M. Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers. Clin Chem Lab Med. 2009;47:993-1000. [PMID: 19569980 DOI: 10.1515/cclm.2009.212] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
33 Dragutinović VV, Radovanović NS, Izrael-Živković LT, Vrvić MM. Detection of gelatinase B activity in serum of gastric cancer patients. World J Gastroenterol 2006; 12(1): 105-109 [PMID: 16440426 DOI: 10.3748/wjg.v12.i1.105] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
34 Seo YS, Park J, Kim JH, Kim JY, Yeon JE, Kim JS, Byun KS, Bak Y. Usefulness of MMP-9/TIMP-1 in Predicting Tumor Recurrence in Patients Undergoing Curative Surgical Resection for Gastric Carcinoma. Dig Dis Sci 2007;52:753-9. [DOI: 10.1007/s10620-006-9535-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
35 Dilshara MG, Kang CH, Choi YH, Kim GY. Mangiferin inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 expression and cellular invasion by suppressing nuclear factor-κB activity. BMB Rep 2015;48:559-64. [PMID: 25739392 DOI: 10.5483/bmbrep.2015.48.10.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
36 Vidal O, Soriano-Izquierdo A, Pera M, Elizalde JI, Palacín A, Castells A, Piqué JM, Volant A, Metges JP. Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers. J Gastrointest Surg. 2008;12:1005-1014. [PMID: 17972143 DOI: 10.1007/s11605-007-0336-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
37 Lempinen M, Lyytinen I, Nordin A, Tervahartiala T, Mäkisalo H, Sorsa T, Isoniemi H. Prognostic value of serum MMP-8, -9 and TIMP-1 in patients with hepatocellular carcinoma. Ann Med 2013;45:482-7. [PMID: 23962148 DOI: 10.3109/07853890.2013.823779] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
38 Wu D, Yang X, Peng H, Guo D, Zhao W, Zhao C, Zhou X. OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma. Carcinogenesis 2017;38:910-9. [PMID: 28911005 DOI: 10.1093/carcin/bgx073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
39 Zhao Y, Liu Y, Lan XM, Xu GL, Sun YZ, Li F, Liu HN. Effect of Dendrobium officinale Extraction on Gastric Carcinogenesis in Rats. Evid Based Complement Alternat Med 2016;2016:1213090. [PMID: 28119756 DOI: 10.1155/2016/1213090] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
40 Liu YF, Guo S, Zhao R, Chen YG, Wang XQ, Xu KS. Correlation of vascular endothelial growth factor expression with tumor recurrence and poor prognosis in patients with pN0 gastric cancer. World J Surg 2012;36:109-17. [PMID: 21773953 DOI: 10.1007/s00268-011-1192-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
41 Nart D, Yaman B, Yilmaz F, Zeytunlu M, Karasu Z, Kiliç M. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation. Liver Transpl. 2010;16:621-630. [PMID: 20440771 DOI: 10.1002/lt.22028] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
42 Yu K, Wang T, Li Y, Wang C, Wang X, Zhang M, Xie Y, Li S, An Z, Ye T. Niclosamide induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in human thyroid cancer in vitro. Biomedicine & Pharmacotherapy 2017;92:403-11. [DOI: 10.1016/j.biopha.2017.05.097] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
43 Lorenc Z, Waniczek D, Lorenc-Podgórska K, Krawczyk W, Domagała M, Majewski M, Mazurek U. Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication. Med Sci Monit 2017;23:1305-11. [PMID: 28293015 DOI: 10.12659/msm.901593] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
44 Peduk S, Dincer M, Tatar C, Ozer B, Kocakusak A, Citlak G, Akinci M. THE ROLE OF SERUM CK-18, MMP-9 AND TIPM-1 LEVELS IN PREDICTING R0 RESECTION IN PATIENTS WITH GASTRIC CANCER. Arq Bras Cir Dig 2018;31:e1401. [PMID: 30539976 DOI: 10.1590/0102-672020180001e1401] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
45 Yang L, Ping YF, Yu X, Qian F, Guo ZJ, Qian C, Cui YH, Bian XW. Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype. Cancer Lett. 2011;310:46-52. [PMID: 21782323 DOI: 10.1016/j.canlet.2011.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 30] [Article Influence: 0.5] [Reference Citation Analysis]
46 Herszenyi L, Hritz I, Pregun I, Sipos F, Juhasz M, Molnar B, Tulassay Z. Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis. World J Gastroenterol 2007;13:676-82. [PMID: 17278189 DOI: 10.3748/wjg.v13.i5.676] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
47 Kim BK, Cheong JH, Im JY, Ban HS, Kim SK, Kang MJ, Lee J, Kim SY, Park KC, Paik S, Won M. PI3K/AKT/β-Catenin Signaling Regulates Vestigial-Like 1 Which Predicts Poor Prognosis and Enhances Malignant Phenotype in Gastric Cancer. Cancers (Basel) 2019;11:E1923. [PMID: 31816819 DOI: 10.3390/cancers11121923] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
48 Sakai H, Ohuchida K, Mizumoto K, Cui L, Nakata K, Toma H, Nagai E, Tanaka M. Inhibition of p600 expression suppresses both invasiveness and anoikis resistance of gastric cancer. Ann Surg Oncol. 2011;18:2057-2065. [PMID: 21347795 DOI: 10.1245/s10434-010-1523-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
49 Mohamed BM, Feighery C, Kelly J, Coates C, O’shea U, Barnes L, Abuzakouk M. Increased Protein Expression of Matrix Metalloproteinases -1, -3, and -9 and TIMP-1 in Patients with Gluten-Sensitive Enteropathy. Dig Dis Sci 2006;51:1862-8. [DOI: 10.1007/s10620-005-9038-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
50 Muthukuru M, Cutler CW. Resistance of MMP9 and TIMP1 to endotoxin tolerance. Pathog Dis 2015;73:ftu003. [PMID: 25951835 DOI: 10.1093/femspd/ftu003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
51 Nayak D, Katoch A, Sharma D, Faheem MM, Chakraborty S, Sahu PK, Chikan NA, Amin H, Gupta AP, Gandhi SG, Mukherjee D, Goswami A. Indolylkojyl methane analogue IKM5 potentially inhibits invasion of breast cancer cells via attenuation of GRP78. Breast Cancer Res Treat 2019;177:307-23. [DOI: 10.1007/s10549-019-05301-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
52 Meng N, Zhao Z, Shi C, Xia L. Inhibiting the Progression of Human Retinoblastoma Cell by Downregulation of MMP-2/MMP-9 Using Short Hairpin RNAs (shRNAs) In Vitro. J Ophthalmol 2020;2020:4912347. [PMID: 32509341 DOI: 10.1155/2020/4912347] [Reference Citation Analysis]
53 Taghizadeh S, Soheili ZS, Sadeghi M, Samiei S, Ranaei Pirmardan E, Kashanian A, Zakeri F, Latifi-Navid H, Shams Najafabadi H. sFLT01 modulates invasion and metastasis in prostate cancer DU145 cells by inhibition of VEGF/GRP78/MMP2&9 axis. BMC Mol Cell Biol 2021;22:30. [PMID: 34011277 DOI: 10.1186/s12860-021-00367-5] [Reference Citation Analysis]
54 Zhao ZS, Wang YY, Ye ZY, Tao HQ. Prognostic value of tumor-related molecular expression in gastric carcinoma. Pathol Oncol Res. 2009;15:589-596. [PMID: 19294533 DOI: 10.1007/s12253-009-9158-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
55 Dicken BJ, Graham K, Hamilton SM, Andrews S, Lai R, Listgarten J, Jhangri GS, Saunders LD, Damaraju S, Cass C. Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg. 2006;243:64-73. [PMID: 16371738 DOI: 10.1097/01.sla.0000194087.96582.3e] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 5.2] [Reference Citation Analysis]
56 Wieczorek E, Galicki M, Tomasik B, Krol M, Jablonska E, Fendler W, Gromadzinska J, Morawiec Z, Wasowicz W, Reszka E. Expression of MMP and TIMP mRNA in Peripheral Blood Leukocytes of Patients with Invasive Ductal Carcinoma of the Breast. Int J Biol Markers 2016;31:309-16. [DOI: 10.5301/jbm.5000203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(11): 2674-2678 [DOI: 10.11569/wcjd.v12.i11.2674] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Fortino V, Maioli E, Torricelli C, Davis P, Valacchi G. Cutaneous MMPs are differently modulated by environmental stressors in old and young mice. Toxicol Lett 2007;173:73-9. [PMID: 17681721 DOI: 10.1016/j.toxlet.2007.06.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
59 Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimäki A, Haglund C. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. J Clin Pathol. 2006;59:618-623. [PMID: 16731602 DOI: 10.1136/jcp.2005.033761] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
60 Peduk S, Tatar C, Dincer M, Ozer B, Kocakusak A, Citlak G, Akinci M, Tuzun IS. The Role of Serum CK18, TIMP1, and MMP-9 Levels in Predicting R0 Resection in Patients with Gastric Cancer. Dis Markers 2018;2018:5604702. [PMID: 29651326 DOI: 10.1155/2018/5604702] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
61 Fountzilas G, Kalogera-Fountzila A, Lambaki S, Wirtz RM, Nikolaou A, Karayannopoulou G, Bobos M, Kotoula V, Murray S, Lambropoulos A, Aravantinos G, Markou K, Athanassiou E, Misailidou D, Kalogeras KT, Skarlos D. MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer. J Oncol 2009;2009:305908. [PMID: 20066159 DOI: 10.1155/2009/305908] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]